The event will see leading clinical research experts from academia, healthcare institutions and the industry deliberate on the state of clinical research in India. Clinical pharmacologist Ranjit Roy Chaudhary will be guest of honour at the event.
Over the two days clinical research professionals will lead discussions on various aspects of clinical research including the regulatory environment and compensation, accreditation, emerging opportunities in clinical research and the challenges and opportunities for stakeholders.
"While there has been a lot of progress in the development of new medicines for life threatening diseases made possible through clinical research, in recent years India has seen a lot negativity around the conduct of clinical research in the country, fuelled by activism and misunderstanding. In addition, we have witnessed uncertainty and unpredictability in the regulatory environment, all of which has led to a slowdown in clinical research in the country," said Suneela Thatte, President, ISCR. "The conference will provide an opportunity for clinical research professionals to converge and discuss how we can address the current challenges so that patients in India, particularly those suffering from debilitating and life-threatening conditions, are not denied access to better treatment or a cure."
In the larger context of India's unique healthcare requirements and the growing incidence of endemic diseases and emerging lifestyle diseases, clinical research is needed to develop new and effective medicines and vaccines to tackle the mammoth disease burden and unmet medical needs. India has 16% of the world's population and 20% of the global disease burden and yet, less than 2% of global trials take place in India.
0 comments:
Post a Comment